Being a member of the TGF-β superfamily, Inhbe is thought to be extensively expressed in the liver, with potential therapeutic implications for metabolic disorders such as obesity and cardiovascular [31,32]. Here, INHBE is linked to obesity due to melanocortin 4 receptor deficiency.